Leah Lawrence

A new study has found an association between body mass index and the risk for multiple myeloma among African Americans in the United States.

The early 21st century has brought with it significant improvements in survival from most common hematologic malignancies for patients aged 65 years or older, but these increases still lag behind those of 50- to 59-year-olds.

Some patients with mantle cell lymphoma may safely defer treatment for their disease, and, in fact, deferral of therapy was an independent predictor of overall survival.

A recent trial found no survival difference in patients with melanoma with a positive sentinel lymph node biopsy who underwent complete lymph node dissection compared with those who did not undergo dissection. However, the trial failed to achieve the required number of events and is, therefore, underpowered.

A new study showed that as cancer survivors age, they have greater declines in certain physical health conditions, as well as an increased risk for depression.

Women who have undergone oophorectomy may be at an increased risk for colorectal cancer, according to the results of a recent study.

Good cancer treatment is not just brilliant diagnostics, treatment, and follow-up care, but includes treating and caring for the whole person, which can include understanding a patient’s sexual orientation and gender identity.

Precautions should be taken when handling chemotherapy and other hazardous drugs, as they can cause acute or chronic effects in nurses and healthcare providers.

First-line osimertinib, a targeted therapy against EGFR mutations, was found to be effective in patients with advanced non–small-cell lung cancer, resulting in a 77% overall response rate.

Adding ixazomib to the combination of lenalidomide/dexamethasone resulted in a more than 35% improvement in the risk for disease progression or death in patients with relapsed or refractory multiple myeloma.

Patients with primary plasma cell leukemia experienced high rates of response and improved progression-free survival when treated with bortezomib, dexamethasone plus doxorubicin or cyclophosphamide followed by transplantation.

Annual screening of people at high risk for pancreatic ductal adenocarcinoma (PDAC) because of CDKN2A mutations was relatively successful and allowed for the detection of disease in time to perform surgery.

A new study is calling for a change in name for certain thyroid tumors. Patients diagnosed with what is currently known as noninvasive encapsulated follicular variant of papillary thyroid carcinoma have a very low risk for recurrence and therefore, researchers have suggested renaming the condition.

The use of a noninvasive colorectal cancer screening test called a multi-target stool DNA test (mt-sDNA) detected the disease in patients who had previously avoided more invasive screening procedures.

Researchers have identified two species of bacteria linked with periodontal disease in healthy individuals that are associated with a risk of developing pancreatic cancer.

Immunotherapy treatment with nivolumab significantly improved survival among patients with recurrent or metastatic head and neck squamous cell carcinoma.

New data indicates that entrectinib has clinical activity in patients with a variety of cancers with gene alterations in NTRK1/2/3, ROS1, or ALK who had never been treated with targeted agents.

More than one-third of patients with advanced melanoma were still alive 5 years after starting treatment with the anti-PD-1 immunotherapy nivolumab, according to long-term phase I data.

Despite a large increase in the diagnosis of thyroid cancer during the last few decades, a new study indicates that thyroid cancer incidence may be leveling off.

A new study has shown that algorithms of dermoscopic criteria used to detect melanoma had only modest levels of accuracy and lacked interobserver agreement among a group of regular dermoscopy users.

Unmarried patients with some of the most common types of cancer had higher risk for mortality compared with their married counterparts.

The American Society of Clinical Oncology released a statement calling for the rapid expansion of use of the human papillomavirus (HPV) vaccine to help protect thousands of people from HPV-associated cancers.

A first-in-man phase I study of CUDC-907, which targets both histone deacetylase and PI3K enzymes, has shown promise in patients with relapsed or refractory multiple myeloma or lymphoma.

Thyroid lesions identified in pediatric patients were often found to have one of the molecular abnormalities commonly seen in adults with thyroid lesions.

Droplet digital polymerase chain reaction–based plasma genotyping exhibited perfect specificity in identifying EGFR and KRAS mutations in patients with advanced non–small-cell lung cancer.

The long-term use of romidepsin in a dose-sparing regimen to treat cutaneous T-cell lymphoma may be a useful strategy to try to prolong disease response.

People who are carriers of two variants of MC1R, a gene that regulates pigmentation, were at increased risk for melanoma regardless of previous UV radiation exposure.

A significant number of children who have completed treatment for acute lymphoblastic leukemia may be experiencing anxiety or depression, according to a new study.

Drinking coffee resulted in a more than 25% decreased risk for developing colorectal cancer, according to the results of a new study.

Researchers from the National Cancer Institute are predicting that the rate of hepatocellular carcinoma (HCC) in the United States will likely decrease by the year 2030.